Home Blog Page 193

Blog

Pharma Marketing Blog

Most popular

Rare Disease Sufferers in US Worse Off Financially & Medically Than...

Pharma Guy - April 15, 2013

FDA DTC Review: The House that Troy Built

Pharma Guy - May 14, 2008

Gov’t SoMo Media Aimed at Teen Smokers: We’re Not Telling You...

Pharma Guy - December 5, 2011

The Socialisation of the Internet is Bogus

Pharma Guy - February 7, 2011

65% of Psychiatrists Say “NO” to Pharma on Facebook!

Pharma Guy - May 12, 2009

Pharma Marketers Should Hire the Directors of the Documentary Off Label...

Pharma Guy - July 31, 2013

My FDA Social Media Hearing Presentations

Pharma Guy - November 5, 2009

FDA Lacks Credibility, Says Judge in Ruling to Allow Access to...

Pharma Guy - March 23, 2009

Want to Know Which Fed Laws Apply to Your mHealth App?...

Pharma Guy - April 16, 2016

Nightly News Trigger Bad Memories of the Great 2008 Depression? Try...

Pharma Guy - February 18, 2009

1...192193194...240 Page 193 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Strategic pharmaceutical launch planning showing healthcare experts, scientific collaboration, and market preparation activities before drug approval.

The Invisible Launch: How Blockbuster Brands Build Demand Before Approval

June 16, 2026

Pharmaceutical marketing concept showing competitive gravity attracting scientific influence, stakeholder engagement, healthcare access, and market leadership.

Beyond Market Share: Why Competitive Gravity Determines Who Wins the Category

June 15, 2026

Pharmaceutical evidence supply chain showing clinical data moving from research and publications to medical guidelines, healthcare professionals, and commercial market influence.

The Evidence Supply Chain: How Clinical Data Becomes Commercial Influence

June 15, 2026